NCT03021603

Brief Summary

Aims. This paper describes the study protocol of a manualized brief positive intervention (BHI). In addition, it reports the on the modification of a hope intervention based on the theoretical proposition - hope theory, and its feasibility when applying to palliative cancer and non-cancer patients. Background. Hope was found to account for therapeutic changes in clients with depressive symptoms or chronic pain. Nevertheless, little is known about the integration of such active ingredients to brief and low intensity psycho-therapeutic interventions to patients receiving palliative care were not adequately tested. Design. The study included two stages: (1) manual development, and (2) a single blinded randomized controlled trial. Methods. Participants will be randomly assigned in equal number into either the brief hope intervention or the controlled arm on completion of the baseline assessment. Participants of the intervention group will be receiving the four-week intervention, while those allocated to the control arm will be receiving the routine care and social chats. The intervention is a manualized program that consists of four sessions at weekly intervals (two face to face sessions and two telephone follow up in between). The core content is modified from an eight sessions hope therapy. Expert panel feedback and trial on targeted populations were completed. Four participants received the program to determine its acceptability prior to feasibility testing. The process and practical considerations were evaluated to allow refinement of the program and to ensure the quality of intervention. Outcome measures comprise of changes in state hope score and the depression scores measured respectively by State Hope Scale and Centre for Epidemiological Study Depression Scale. The secondary outcomes are the common signs and symptoms in cancer patients measured by The Condensed Memorial Symptom Assessment Scale. Data collection will be done prior to the intervention (baseline), immediately and one month after the intervention. Additional use of qualitative interview to explore their experiences in the intervention, including satisfaction with the intervention and the treatment fidelity will be conducted.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 16, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

January 23, 2017

Status Verified

January 1, 2017

Enrollment Period

1.2 years

First QC Date

January 12, 2017

Last Update Submit

January 20, 2017

Conditions

Keywords

Hopepsychotherapypalliativelow-intensity intervention

Outcome Measures

Primary Outcomes (1)

  • State Hope Scale (SHS)

    The SHS is a self-report instrument consisting of 6 items (Snyder et al., 1996) used to assess the two ongoing hope indices related to the pathways and agency of hopeful thinking. For instance, 'I can think of many ways to reach my current goals'. It takes approximately 5 minutes to complete. It is rated on an 8-point scale with 1 = definitely false and 8 = definitely true.

    4 weeks

Secondary Outcomes (1)

  • The Condensed Memorial Symptom Assessment Scale (CMSAS)

    4 weeks

Other Outcomes (2)

  • Center for Epidemiological Studies Depression Scale (CES-D)

    4 weeks

  • Healthcare Resource Utilization

    3 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

This is a 4-week Brief Hope Intervention Four sessions in total: two face-to-face sessions (1-hour) and two telephone follow up sessions (30 mins) in between. Homework : A booklet is prepared for the participants for reviewing their planned goals and recording achieved targets.

Behavioral: Brief Hope Intervention

Control Group

EXPERIMENTAL

Standard care: Clinic follow up and normal hospital care. Logistic call and social communication On completion of the 4-week standard care, the 4-session brief hope intervention will be offered

Behavioral: Brief Hope Intervention

Interventions

The present Brief Hope Intervention (BHI) is a four-weeks individual intervention: Hope enhancement strategies included sharing and recalling past successes, hope-based goal mapping exercises, examining possible pathways to reach the targeted goals, hope visualization exercise and positive self-talk. Purpose: help participants to develop positive thoughts. The programme consists of four sessions: Two face-to-face sessions (1-hour) and two telephone follow up (30 mins) Homework: A booklet is prepared for the participants for reviewing their planned goals and recording achieved targets.

Control GroupIntervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Clinically diagnosed to have cancer or patients receiving palliative care
  • Willing to participate in face-to-face activities and telephone follow up
  • Alert and oriented, able to sustain for approximately one hour of attention and interaction
  • Communicable in Cantonese, able to read and write Chinese
  • Could be reached by phone

You may not qualify if:

  • Patients having one or above of the below conditions will be excluded from the study.
  • Patients who have planned operation or further chemotherapy and/or radiotherapy within three months
  • Patients who are unable to communicate in Cantonese
  • Patient who has hearing deficit
  • Patient who are disoriented, delirious or cognitively impaired
  • Patients who have been or is receiving counseling or psychotherapy
  • Patients who are clinically depressed diagnosed by medical doctors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Chan Kitty, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 16, 2017

Study Start

March 1, 2017

Primary Completion

April 30, 2018

Study Completion

May 1, 2018

Last Updated

January 23, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will share

Publication of results in May 2018